Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Conferences

ecancer travels so that you don't have to. Explore the latest conference coverage in global oncology and find out where we are going next.

AACR 2020

27 - 28 Apr 2020

Virtual Annual Meeting

AACR COVID-19 and cancer: Immunotherapy safe for patients with COVID-19

AACR COVID-19 and cancer: Immunotherapy safe for patients with COVID-19

AACR 2020: Diagnosing brain tumours with a blood test

AACR 2020: Diagnosing brain tumours with a blood test

AACR 2020: Personalised cancer vaccine plus atezolizumab shows clinical activity in patients with advanced solid tumours

AACR 2020: Personalised cancer vaccine plus atezolizumab shows clinical activity in patients with advanced solid...

AACR 2020: Real-world data shows immunotherapy after melanoma surgery yields survival benefit

AACR 2020: Real-world data shows immunotherapy after melanoma surgery yields survival benefit

AACR 2020: Study shows immunotherapy prior to surgery may help destroy high-risk breast cancer

AACR 2020: Study shows immunotherapy prior to surgery may help destroy high-risk breast cancer

AACR 2020: Study of nearly 10,000 women explores feasibility and safety of multi-cancer blood test

AACR 2020: Study of nearly 10,000 women explores feasibility and safety of multi-cancer blood test

AACR 2020: New therapy with potential benefit for underserved patients with lung and ovarian cancers

AACR 2020: New therapy with potential benefit for underserved patients with lung and ovarian cancers

AACR 2020: Continuous dosing improves progression-free survival for melanoma patients with common mutations

AACR 2020: Continuous dosing improves progression-free survival for melanoma patients with common mutations

AACR 2020: Study finds no overall survival benefit, but improved quality of life with talazoparib in advanced BRCA-mutated breast cancer

AACR 2020: Study finds no overall survival benefit, but improved quality of life with talazoparib in advanced BRCA...

More from ecancer